afatinib dimaleate (MedChemExpress)
MedChemExpress is a verified supplier 
MedChemExpress manufactures this product 
95
Structured Review
MedChemExpress
afatinib dimaleate
Afatinib Dimaleate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/afatinib+dimaleate/Afatinib/pm42025967-70-48-70
Average 95 stars, based on 74 article reviews
Afatinib Dimaleate, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 95/100, based on 74 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/afatinib+dimaleate/Afatinib/pm42025967-70-48-70
Average 95 stars, based on 74 article reviews
afatinib dimaleate - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Sequencing:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Control:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Positive Control:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Immunohistochemistry:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Formalin-fixed Paraffin-Embedded:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Western Blot:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Expressing:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Plasmid Preparation:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Activity Assay:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Stable Transfection:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Inhibition:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Derivative Assay:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Mutagenesis:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. Comparison:Article Title: BRAF V600E -Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling Article Snippet: Cobimetinib was generously provided by Genentech Inc. |